Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bryce

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|September 2, 1994
Aza-tricyclic substance P antagonistsJ A Lowe, S E Drozda, S McLean, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and structure-activity relationships of CP-122,721, a second-generation NK-1 receptor antagonistT J Rosen, K J Coffman, S McLean, et al.
Science (New York, N.Y.)|January 25, 1991
Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonistS McLean, A H Ganong, T F Seeger, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1993
Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptorS McLean, A Ganong, P A Seymour, et al.
Journal of Medicinal Chemistry|July 10, 1992
The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisstJ A Lowe, S E Drozda, R M Snider, et al.
Regulatory Peptides|July 2, 1993
Discovery of CP-96,345 and its characterization in disease models involving substance PJ A Lowe, S E Drozda, R M Snider, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2009
Biaryl piperidines as potent and selective delta opioid receptor ligandsSpiros Liras, Stanton F McHardy, Martin P Allen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Origins of equine dentistryWilliam Timothy Treal Taylor, Jamsranjav Bayarsaikhan, Tumurbaatar Tuvshinjargal, et al.
Science Translational Medicine|April 28, 2012
Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autismJill L Silverman, Daniel G Smith, Stacey J Sukoff Rizzo, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptorS McLean, A Ganong, P A Seymour, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|September 2, 1994
Aza-tricyclic substance P antagonistsJ A Lowe, S E Drozda, S McLean, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and structure-activity relationships of CP-122,721, a second-generation NK-1 receptor antagonistT J Rosen, K J Coffman, S McLean, et al.
Science (New York, N.Y.)|January 25, 1991
Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonistS McLean, A H Ganong, T F Seeger, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1993
Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptorS McLean, A Ganong, P A Seymour, et al.
Journal of Medicinal Chemistry|July 10, 1992
The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisstJ A Lowe, S E Drozda, R M Snider, et al.
Regulatory Peptides|July 2, 1993
Discovery of CP-96,345 and its characterization in disease models involving substance PJ A Lowe, S E Drozda, R M Snider, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2009
Biaryl piperidines as potent and selective delta opioid receptor ligandsSpiros Liras, Stanton F McHardy, Martin P Allen, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Origins of equine dentistryWilliam Timothy Treal Taylor, Jamsranjav Bayarsaikhan, Tumurbaatar Tuvshinjargal, et al.
Science Translational Medicine|April 28, 2012
Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autismJill L Silverman, Daniel G Smith, Stacey J Sukoff Rizzo, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptorS McLean, A Ganong, P A Seymour, et al.
Pageof 3